STEVEN D WITTLIN, MD
Osteopathic Medicine at Elmwood Ave, Rochester, NY

License number

New York 136396

Organization information

See more information about STEVEN D WITTLIN at bizstanding.com

Endocrine Practice Group - Alvin L Ureles MD

601 Elmwood Ave #693, Rochester, NY 14642

Doing business as:

Endocrine Practice Group - Steven D Wittlin MD

Site:

urmc.rochester.edu

Phone:

(585) 275-2901 (Phone)

Categories:

Endocrinology & Metabolism Physicians & Surgeons, Physicians & Surgeons

Products:

Military & Veteran's Services

Professional information

1,5-Anhydroglucitol (1,5-Ag) Assay And A1C/1,5-Ag Assay Combination For Measuring Blood Glucose Excursions In General And Postprandial Hyperglycemia In Diabetic Patients

US Patent:

2008018, Aug 7, 2008

Filed:

Apr 21, 2006

Appl. No.:

11/912171

Inventors:

John B. Buse - Chapel Hill NC, US
Kathleen Dungan - Durham NC, US
Steven D. Wittlin - Rochester NY, US
Eric A. Button - Kannapolis NC, US
Shuhei Kato - Tokyo, JP
Toshio Tanabe - Tokyo, JP

Assignee:

Nippon Kayaku Kabushiki Kisha - Tokyo
Toyota Tsusho America Inc. - New York NY

International Classification:

C12Q 1/54, C12M 1/00

US Classification:

435 14, 4352871

Abstract:

The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.